Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) FCF Margin (2016 - 2025)

Anaptysbio's FCF Margin history spans 10 years, with the latest figure at 130.78% for Q4 2025.

  • For Q4 2025, FCF Margin rose 39711.0% year-over-year to 130.78%; the TTM value through Dec 2025 reached 11.25%, up 24400.0%, while the annual FY2025 figure was 8.4%, 15667.0% up from the prior year.
  • FCF Margin reached 130.78% in Q4 2025 per ANAB's latest filing, up from 54.74% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 130.78% in Q4 2025 to a low of 2636.6% in Q4 2021.
  • Average FCF Margin over 5 years is 691.27%, with a median of 250.77% recorded in 2024.
  • Peak YoY movement for FCF Margin: crashed -269919bps in 2021, then skyrocketed 242348bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 2636.6% in 2021, then skyrocketed by 92bps to 213.12% in 2022, then crashed by -80bps to 384.55% in 2023, then skyrocketed by 31bps to 266.34% in 2024, then soared by 149bps to 130.78% in 2025.
  • Per Business Quant, the three most recent readings for ANAB's FCF Margin are 130.78% (Q4 2025), 54.74% (Q3 2025), and 180.94% (Q2 2025).